Background and objective: Acinetobacter baumannii (A. baumannii) is an important
nosocomial pathogen that not only possesses intrinsic resistance to many classes of …

Introduction. This study aimed to identify, assess, and isolate strong lactobacilli
demonstrating broad antibacterial and anti‐biofilm activity against drug‐resistant strains of …

Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) have limited
therapeutic options. Sulbactam-durlobactam is a combination of two βlactamase inhibitors …

Introduction: Our goal was to investigate the antimicrobial resistance due to beta-lactamase
genes and virulent determinants (biofilm-forming ability) expressed by Acinetobacter …

Background: Acinetobacter baumannii is a clinically significant pathogen with a high
incidence of multidrug resistance that is associated with life-threatening nosocomial …

Objective. Since a urinary tract infection (UTI) is easy to relapse and difficult to treat, the
antibiotic resistance rate has increased year by year in recent years. This study was to …

Acinetobacter (A.) baumannii is one of the major nosocomial pathogens worldwide. It is
associated with bloodstream infection, pneumonia, meningitis, urinary tract, soft tissue, and …

This research aimed to investigate the microbial spectrum of microorganisms that cause
ventilator-associated pneumonia (VAP) among ICU patients in the selected hospital …

Probiotics based on bacteria of the genus Bacillus with a multifactorial mechanism of action
are considered as a possible alternative to antibiotics in the treatment of purulent wounds …

Acinetobacter baumannii is a Priority 1 pathogen under the WHO list for research and
discovery of new antibiotics. The epidemiology of the pathogen suggests its relevance as an …